PERSPECTA

News from every angle

← Back to headlines

Roche Multiple Sclerosis Drug Meets Main Goal in Late-Stage Trial - WSJ

Roche Multiple Sclerosis Drug Meets Main Goal in Late-Stage Trial  WSJ

2 Mar, 16:31 — 2 Mar, 16:31
PostShare
ℹOnly 1 source covers this story

Read at source (1 outlet)

wsj2d ago

Roche Multiple Sclerosis Drug Meets Main Goal in Late-Stage Trial - WSJ

Roche Multiple Sclerosis Drug Meets Main Goal in Late-Stage Trial  WSJ

Read full article →

Related Stories

Beware of fake HIV test kits in circulation, NAFDAC warns Nigerians

6m ago

Heavier cases for the eating disorder team and faster illnesses

14m ago

8 most common misconceptions about proteins and what science says

20m ago

Otti begins upgrade of primary health centres in Abia

23m ago